803
Participants
Start Date
September 30, 2013
Primary Completion Date
September 30, 2014
Study Completion Date
April 30, 2015
Placebo (for alirocumab)
Solution for injection, subcutaneous injections in the abdomen, thigh, or outer area of upper arm with an auto-injector.
Alirocumab
Solution for injection, subcutaneous injection in the abdomen, thigh, or outer area of upper arm with an auto-injector.
Statin
Atorvastatin, rosuvastatin and simvastatin at stable dose in participants with stable statin therapy
Chandler
Goodyear
Carmichael
Fresno
West Hills
Wildomar
Colorado Springs
Golden
Boynton Beach
Jacksonville
Safety Harbor
Atlanta
Boise
Meridian
Chicago
Gurnee
Evansville
Indianapolis
Iowa City
Kansas City
Louisville
Monroe
Auburn
Methuen
Minneapolis
St Louis
Rochester
Farmville
Greensboro
Greenville
Raleigh
Wilson
Cincinnati
Marion
Tulsa
Philadelphia
Wyomissing
Knoxville
Dallas
Houston
San Antonio
Orem
Salt Lake City
South Jordan
Norfolk
Richmond
Spokane
Tacoma
Kenosha
Varna
Sofia
Victoria
Oshawa
Toronto
Woodstock
Montreal
Québec
Trois-Rivières
Budapest
Debrecen
Nyíregyháza
Ajka
Nagykanizsa
Zalaegerszeg
Tel Litwinsky
Safed
Ofakim
Holon
Tel Litwinsky
Skedsmokorset
Oslo
Svidník
Bratislava
Bratislava
Lučenec
Považská Bystrica
Worton Grange, Reading
Edgbaston
Llanishen
Choley
Waterloo
Lloyd Street North
Glasgow
Collaborators (1)
Sanofi
INDUSTRY
Regeneron Pharmaceuticals
INDUSTRY